CMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cantel Medical has the Financial Strength Rank of 0.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.Cantel Medical's Interest Coverage for the quarter that ended in Apr. 2021 was 3.07. Cantel Medical's debt to revenue ratio for the quarter that ended in Apr. 2021 was 0.75. As of today, Cantel Medical's Altman Z-Score is 3.09.
For the Medical Instruments & Supplies subindustry, Cantel Medical's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Cantel Medical's Financial Strength distribution charts can be found below:
* The bar in red indicates where Cantel Medical's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Cantel Medical's Interest Expense for the months ended in Apr. 2021 was $-15 Mil. Its Operating Income for the months ended in Apr. 2021 was $46 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2021 was $903 Mil.
Cantel Medical's Interest Coverage for the quarter that ended in Apr. 2021 is
Interest Coverage | = | -1 | * | Operating Income (Q: Apr. 2021 ) | / | Interest Expense (Q: Apr. 2021 ) |
= | -1 | * | 45.524 | / | -14.845 | |
= | 3.07 |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Cantel Medical's Debt to Revenue Ratio for the quarter that ended in Apr. 2021 is
Debt to Revenue Ratio | = | Total Debt (Q: Apr. 2021 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (40.082 | + | 903.318) | / | 1255.812 | |
= | 0.75 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Cantel Medical has a Z-score of 3.09, indicating it is in Safe Zones. This implies the Z-Score is strong.
Good Sign:
Altman Z-score of 3.09 is strong.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cantel Medical (NYSE:CMD) Financial Strength Explanation
The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.
Cantel Medical has the Financial Strength Rank of 0.
Thank you for viewing the detailed overview of Cantel Medical's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Ann E Berman | director | 255 STATE STREET, BOSTON MA 02109 |
Jeffrey Z Mann | officer: SVP, General Counsel | 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
George L Fotiades | director, officer: Chief Executive Officer | 281 SUMMIT AVENUE, SUMMIT NJ 07901 |
Charles M Diker | director, 10 percent owner, officer: Chairman | ONE NEW YORK PLAZA, NEW YORK NY 10004 |
Shaun M. Blakeman | officer: SVP - CFO | C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424 |
Jean Casner | officer: SVP and CHRO | 150 CLOVE ROAD, LITTLE FALLS NJ 07424 |
Brian Capone | officer: SVP and Princ. Accounting Ofr | 150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424 |
Peter G Clifford | officer: President and COO | 40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047 |
Seth M Yellin | officer: Executive Vice President | 150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424 |
Laura L Forese | director | 849 STONEWALL COURT FRANKLIN LAKES NJ 07417 |
Peter Pronovost | director | JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231 |
Anthony B Evnin | director | C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018 |
Ronnie Myers | director | TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595 |
Alan R Batkin | director | 399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022 |
Karen Prange | director | 1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316 |
From GuruFocus
By PRNewswire PRNewswire • 11-24-2020
By PRNewswire PRNewswire • 05-13-2020
By PRNewswire PRNewswire • 01-12-2021
By PRNewswire PRNewswire • 01-13-2021
By PRNewswire PRNewswire • 08-03-2020
By PRNewswire PRNewswire • 10-01-2020
By PRNewswire PRNewswire • 05-22-2020
By Business Wire Business Wire • 01-14-2021
By PRNewswire PRNewswire • 04-01-2020
By PRNewswire PRNewswire • 09-03-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.